Pfizer, as the sole licensed supplier, is currently experiencing supply problems with Ketalar 10mg/ml in the UK. The 10mg/ml is anticipated to be out of stock from the end of March until the end of April. Supplies of the 50mg/ml product are unaffected and will remain available during this time. Imports are available; this memo discusses risk management issues related to their use.
NOTE: Although the shortage has resolved, the memo has been retained, as this product is subject to intermittent shortages. The contents of the memo, however, have not been updated since the publication date.